Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIC-1001 for Visceral Pain in Sedation-Free Colonoscopy
NCT01926444Phase 2Completed
- Sponsor
- gIcare Pharma Inc
- Start
- Jul 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of trimebutine 3-thiocarbamoylbenzenesulfonate in Visceral pain, sponsored by gIcare Pharma Inc. Started Jul 2013; status: completed.
02
Drugs
trimebutine 3-thiocarbamoylbenzenesulfonate
03
Conditions
Visceral pain
Beyond the preview
Go deeper on NCT01926444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01926444.